FDA: Mela Sciences’s Melafind Skin Cancer Biopsy Replacement May Cause “More Harm Than Good”

November 17, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Mass Device -- The Food & Drug Administration raises concerns over Mela Sciences Inc.'s melanoma-detection device two days ahead of its pre-market approval vote by an agency panel.

Twitter
LinkedIn
Facebook
Email
Print

Food and Drug Administration (FDA)